—
C+
C+ The full Closelook — membership. Open the C+ overview

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Amneal Pharmaceuticals, Inc. Class A Common Stock ranks 5 of 11 in its cohort on the Closelook composite (53/100) — the cohort is led by argenx NV ADR at 64/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 53 85 56 43 ok 5.1%
ALKS Alkermes Plc 53 75 51 23 info 16.1%
BHC.TO Bausch Health Companies Inc 53 49 69 84 info 28.5%
ALM.MC Almirall S.A. 52 25 44 67 warn 23.2%
FAGR.BR Fagron NV 51 40 53 61 info 12.3%
TAK Takeda Pharmaceutical Co Ltd ADR 50 70 37 81 ok 0.3%
APTX.TO Apotex Health Corp 48 63 55 50 — —
ARGX argenx NV ADR 64 78 72 27 ok 7.2%
ONC BeiGene, Ltd. 63 75 62 33 ok 8.2%
MEDP Medpace Holdings Inc 63 86 74 31 ok 9.3%
REGN Regeneron Pharmaceuticals Inc 60 64 69 52 bull 8.1%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Amneal Pharmaceuticals, Inc. Class A Common Stock's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Alkermes Plc (ALKS), Bausch Health Companies Inc (BHC.TO), Almirall S.A. (ALM.MC), Fagron NV (FAGR.BR), Takeda Pharmaceutical Co Ltd ADR (TAK), Apotex Health Corp (APTX.TO), argenx NV ADR (ARGX), BeiGene, Ltd. (ONC) and others.

How does AMRX score against its peers?

Amneal Pharmaceuticals, Inc. Class A Common Stock's composite reads 53/100, ranking 5 of 11 in its cohort as of 2026-09-18; the cohort's highest composite is argenx NV ADR at 64/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.